Literature DB >> 26119670

PnPP-19, a Synthetic and Nontoxic Peptide Designed from a Phoneutria nigriventer Toxin, Potentiates Erectile Function via NO/cGMP.

Carolina Nunes Silva1, Kenia Pedrosa Nunes2, Fernanda Silva Torres1, Juliana Silva Cassoli1, Daniel Moreira Santos1, Flávia De Marco Almeida1, Alessandra Matavel3, Jader Santos Cruz1, Arthur Santos-Miranda1, Allancer Divino C Nunes4, Carlos Henrique Castro4, Ricardo Andrés Machado de Ávila5, Carlos Chávez-Olórtegui1, Stephanie Stransky Láuar1, Liza Felicori1, Jarbas Magalhães Resende6, Elizabeth Ribeiro da Silva Camargos7, Márcia Helena Borges3, Marta Nascimento Cordeiro3, Steve Peigneur8, Jan Tytgat8, Maria Elena de Lima9.   

Abstract

PURPOSE: We designed a peptide, PnPP-19, comprising the potential active core of the Phoneutria nigriventer native toxin PnTx2-6. We investigated its role on erectile function, and its toxicity and immunogenicity.
MATERIALS AND METHODS: Erectile function was evaluated by the intracavernous pressure-to-mean arterial pressure ratio during electrical field stimulation on rat pelvic ganglia. Cavernous strips were contracted with phenylephrine and relaxation was induced by electrical field stimulation with or without PnPP-19 (10(-8) M). Activity on sodium channels was evaluated by electrophysiological screening of transfected channels on Xenopus oocytes and dorsal root ganglion cells. Antibodies were detected by indirect enzyme-linked immunosorbent assay in mice previously treated with the peptide. Histopathological studies were performed with mouse organs treated with different doses of PnPP-19.
RESULTS: PnPP-19 was able to potentiate erection at 4 and 8 Hz in vivo and ex vivo. It showed no toxicity and low immunogenicity in mice, and did not affect sodium channels or rat hearts. PnPP-19 increased cyclic guanosine monophosphate levels at 8 Hz. This effect was inhibited by L-NAME (10(-4) M). Erectile function was partially inhibited by 7-nitroindazole (10(-5) M), a selective inhibitor of neuronal nitric oxide synthase.
CONCLUSIONS: PnPP-19 potentiates erection in vivo and ex vivo via the nitric oxide/cyclic guanosine monophosphate pathway. It does not affect sodium channels or rat hearts and shows no toxicity and low immunogenicity. These findings make it a promising candidate as a novel drug in the therapy of erectile dysfunction.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Phoneutria nigriventer; Tx2-6 protein; chemistry techniques; drug evaluation; penile erection; peptide; preclinical; synthetic

Mesh:

Substances:

Year:  2015        PMID: 26119670     DOI: 10.1016/j.juro.2015.06.081

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Sexual dysfunction: Brazilian spider toxin analogue potentiates erection via NO pathway.

Authors:  Annette Fenner
Journal:  Nat Rev Urol       Date:  2015-07-14       Impact factor: 14.432

2.  PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase.

Authors:  A C N Freitas; D F Pacheco; M F M Machado; A K Carmona; I D G Duarte; M E de Lima
Journal:  Br J Pharmacol       Date:  2016-03-10       Impact factor: 8.739

3.  A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems.

Authors:  Daniela da Fonseca Pacheco; Ana Cristina Nogueira Freitas; Adriano Monteiro C Pimenta; Igor Dimitri Gama Duarte; Maria Elena de Lima
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2016-12-21

4.  Ocellatin peptides from the skin secretion of the South American frog Leptodactylus labyrinthicus (Leptodactylidae): characterization, antimicrobial activities and membrane interactions.

Authors:  Karla A G Gusmão; Daniel M Dos Santos; Virgílio M Santos; María Esperanza Cortés; Pablo V M Reis; Vera L Santos; Dorila Piló-Veloso; Rodrigo M Verly; Maria Elena de Lima; Jarbas M Resende
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-01-19

5.  Phoneutria nigriventer Spider Toxin PnTx2-1 (δ-Ctenitoxin-Pn1a) Is a Modulator of Sodium Channel Gating.

Authors:  Steve Peigneur; Ana Luiza B Paiva; Marta N Cordeiro; Márcia H Borges; Marcelo R V Diniz; Maria Elena de Lima; Jan Tytgat
Journal:  Toxins (Basel)       Date:  2018-08-21       Impact factor: 4.546

Review 6.  Brown Spider (Loxosceles) Venom Toxins as Potential Biotools for the Development of Novel Therapeutics.

Authors:  Daniele Chaves-Moreira; Fernando Hitomi Matsubara; Zelinda Schemczssen-Graeff; Elidiana De Bona; Vanessa Ribeiro Heidemann; Clara Guerra-Duarte; Luiza Helena Gremski; Carlos Chávez-Olórtegui; Andrea Senff-Ribeiro; Olga Meiri Chaim; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2019-06-19       Impact factor: 4.546

7.  Priapism following a juvenile Russell's viper bite: An unusual case report.

Authors:  Subramanian Senthilkumaran; Harry F Williams; Ketan Patel; Steven A Trim; Ponniah Thirumalaikolundusubramanian; Sakthivel Vaiyapuri
Journal:  PLoS Negl Trop Dis       Date:  2021-03-25

8.  The Peptide PnPP-19, a Spider Toxin Derivative, Activates μ-Opioid Receptors and Modulates Calcium Channels.

Authors:  Ana C N Freitas; Steve Peigneur; Flávio H P Macedo; José E Menezes-Filho; Paul Millns; Liciane F Medeiros; Maria A Arruda; Jader Cruz; Nicholas D Holliday; Jan Tytgat; Gareth Hathway; Maria E de Lima
Journal:  Toxins (Basel)       Date:  2018-01-15       Impact factor: 4.546

9.  Antioxidative mechanism of Lycium barbarum polysaccharides promotes repair and regeneration following cavernous nerve injury.

Authors:  Zhan-Kui Zhao; Hong-Lian Yu; Bo Liu; Hui Wang; Qiong Luo; Xie-Gang Ding
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

10.  PnPP-19 Peptide as a Novel Drug Candidate for Topical Glaucoma Therapy Through Nitric Oxide Release.

Authors:  Carolina Nunes da Silva; Lays Fernanda Nunes Dourado; Maria Elena de Lima; Armando da Silva Cunha-Jr
Journal:  Transl Vis Sci Technol       Date:  2020-07-22       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.